View Older Stories View More Recent Stories
-
Eli Lilly (LLY) PT Raised to $1,000 at Truist Securities
-
Midday movers: Apple, Eli Lilly rise; Coinbase falls
-
Eli Lilly & Co. (LLY) Declares $1.30 Quarterly Dividend; 0.6% Yield
-
ResMed, Inspire Medical slump after Lilly's positive Zepbound data; Citi downgrades
-
ResMed (RMD), Inspire Medical (INSP) sink following Lilly's sleep apnea results
-
Eli Lilly's (LLY) tirzepatide reduced obstructive sleep apnea (OSA) severity
-
Eli Lilly & Co. (LLY) 30-day option implied volatility flat
-
Eli Lilly & Co. (LLY) option IV near lower end of range
-
Eli Lilly & Co. (LLY) option IV flat as share price near record high
-
Popular stocks with increasing volume: ORCL LLY XOM GME SQ T MS SLB BAC AFRM
-
Midday movers: Coinbase, Yext fall; Apple, GM rise
-
Barclays Reiterates Overweight Rating on Eli Lilly (LLY)
-
FDA Panel Votes 11-0 Lilly's (LLY) Drug's Benefits Outweigh Risks - Bloomberg
-
Top pharma stocks to own in 2024 – Citi
-
Why BMO remains bullish on Eli Lilly (LLY) stock
-
Could Eli Lilly & Co. (LLY) be the first $1trn biopharma stock?
-
7 Themes to watch in 2024
-
Eli Lilly, UPS ahead, SoftBank's surprise loss - what's moving markets
-
Wall Street ticks higher, but chip stocks tumble

